Solving the Antidepressant Efficacy Question: Effect Sizes in Major Depressive Disorder

被引:50
|
作者
Voehringer, Paul A. [1 ,2 ]
Ghaemi, S. Nassir [3 ]
机构
[1] Tufts Med Ctr, Dept Psychiat, Mood Disorders Program, Boston, MA 02111 USA
[2] Univ Chile, Fac Med, Hosp Clin, Santiago 7, Chile
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
antidepressants; effect size; meta-analysis; randomized clinical trials; STAR-ASTERISK-D; MAINTENANCE TREATMENT; BIPOLAR DISORDER; VENLAFAXINE; OUTCOMES; DISCONTINUATION; SEVERITY; PREVENT;
D O I
10.1016/j.clinthera.2011.11.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Numerous reviews and meta-analyses of the antidepressant literature in major depressive disorders (MDD), both acute and maintenance, have been published, some claiming that antidepressants are mostly ineffective and others that they are mostly effective, in either acute or maintenance treatment. Objective: The aims of this study were to review and critique the latest and most notable antidepressant MDD studies and to conduct our own reanalysis of the US Food and Drug Administration database studies specifically analyzed by Kirsch et al. Methods: We gathered effect estimates of each MDD study. In our reanalysis of the acute depression studies, we corrected analyses for a statistical floor effect so that relative (instead of absolute) effect size differences were calculated. We also critiqued a recent meta-analysis of the maintenance treatment literature. Results: Our reanalysis showed that antidepressant benefit is seen not only in severe depression but also in moderate depression and confirmed a lack of benefit for antidepressants over placebo in mild depression. Relative antidepressant versus placebo benefit increased linearly from 5% in mild depression to 12% in moderate depression to 16% in severe depression. The claim that antidepressants are completely ineffective, or even harmful, in maintenance treatment studies involves unawareness of the enriched design effect, which, in that analysis, was used to analyze placebo efficacy. The same problem exists for the standard interpretation of those studies, although they do not prove antidepressant efficacy either, since they are biased in favor of antidepressants. Conclusions: In sum, we conclude that antidepressants are effective in acute depressive episodes that are moderate to severe but are not effective in mild depression. Except for the mildest depressive episodes, correction for the statistical floor effect proves that antidepressants are effective acutely. These considerations only apply to acute depression, however. For maintenance, the long-term efficacy of antidepressants is unproven, but the data do not support the conclusion that they are harmful. (Clin Ther. 2011;33:B49-B61) (C) 2011 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:B49 / B61
页数:13
相关论文
共 50 条
  • [31] Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder
    Cameron, Isobel M.
    Reid, Ian C.
    MacGillivray, Steve A.
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 166 : 48 - 58
  • [32] Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder
    Amsterdam, Jay D.
    Williams, David
    Michelson, David
    Adler, Lenard A.
    Dunner, David L.
    Nierenberg, Andrew A.
    Reimherr, Frederick W.
    Schatzberg, Alan F.
    NEUROPSYCHOBIOLOGY, 2009, 59 (04) : 227 - 233
  • [33] The Neural Effects of Antidepressant Medication on Adults With Major Depressive Disorder: A Meta-Analysis
    Santos, Shay
    Miller, Chris
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S345 - S345
  • [34] Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder
    Hunter, Aimee M.
    Cook, Ian A.
    Tartter, Molly
    Sharma, Simi K.
    Disse, Gregory D.
    Leuchter, Andrew F.
    PSYCHOPHARMACOLOGY, 2015, 232 (20) : 3833 - 3840
  • [35] Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
    Mosiolek, Anna
    Mosiolek, Jadwiga
    Jakima, Slawomir
    Pieta, Aleksandra
    Szulc, Agata
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [36] Costs Associated With Changes in Antidepressant Treatment in a Managed Care Population With Major Depressive Disorder
    Schultz, Jennifer
    Joish, Vijay
    PSYCHIATRIC SERVICES, 2009, 60 (12) : 1604 - 1611
  • [37] Antidepressant Effect of Combined Ketamine and Electroconvulsive Therapy on Patients With Major Depressive Disorder: A Randomized Trial
    Alizadeh, Narges
    Maroufi, Azad
    Nasseri, Karim
    Najafabadi, Seyed
    Taghiabad, Ali
    Gharibi, Fardin
    Esfandiari, Gholam
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2015, 9 (03)
  • [38] Addition of aerobic exercise to drug monotherapy with antidepressant effect for the treatment of major depressive disorder in adults
    Sanhueza Pasten, Camila
    Caneo, Constanza
    MEDWAVE, 2022, 22 (01):
  • [39] Genetic disposition to inflammation and response to antidepressants in major depressive disorder
    Zwicker, Alyson
    Fabbri, Chiara
    Rietschel, Marcella
    Hauser, Joanna
    Mors, Ole
    Maier, Wolfgang
    Zobel, Astrid
    Farmer, Anne
    Aitchison, Katherine J.
    McGuffin, Peter
    Lewis, Cathryn M.
    Uher, Rudolf
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 105 : 17 - 22
  • [40] Effect of insomnia in the major depressive disorder
    Xu, Guohong
    Li, Xiaoling
    Xu, Caixia
    Xie, Guojun
    Liang, Jiaquan
    BMC NEUROLOGY, 2022, 22 (01)